Reports Q2 revenue $39.73M, consensus $2.03M. Revenue in Q2 was primarily from government contracts related to the BARDA contract awarded in June 2024. Reports cash, cash equivalents and investments of $26.3M as of June 30, 2025. Currently, Vaxart (VXRT) anticipates cash runway into Q1 of 2026.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VXRT:
- Options Volatility and Implied Earnings Moves Today, August 13, 2025
- Options Volatility and Implied Earnings Moves This Week, August 11 – August 14, 2025
- VXRT Earnings this Week: How Will it Perform?
- Vaxart issues letter to shareholders related to reverse stock split proposal
- Vaxart Stock Approved for OTCQX Best Market